Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Merck (MRK) Prices $8B Senior Unsecured Notes Offering
-
-
-
-
-
-
-
Merck (MRK) Prices $4.5 Billion Debt Offering
-
-
-
-
-
-
-
Merck (MRK) PT Raised to $64 at Deutsche Bank
-
-
-
-
-
-
-
Merck (MRK) PT Lowered to $59 at Deutsche Bank As Competive Pressures Mount
-
-
-
-
-
-
-
After-Hours Stock Movers 01/10: (ENPH) (AKAO) (MRK) Higher; (PE) (BRG) (JNPR) Lower (more...)
-
-
-
-
-
-
-
AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes
-
-
-
-
-
-
-
Gilead (GILD), AbbVie (ABBV) Buy Ratings Maintained at Deutsche Bank Following Merck (MRK) HCV Data
-
55,972 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

